Cell Receptor Company

Cell Receptor is a startup company based in Geneva that focuses on developing pharmacological therapies to prevent cancer metastasis and control autoimmune diseases. They possess unique knowledge of a basic control mechanism of cell growth that was previously unknown and have developed a new method for the prevention of cancer metastases. The company is planning to fund a clinical trial to prove its concept and expand its activities. The treatment has the potential to inhibit cancer metastasis at reasonable costs, which is expected to generate substantial sales.